COVID-19 NATIONAL EMERGENCY TELEMEDICINE AND CONTROLLED SUBSTANCES
• DEA- registered practitioners in all areas of the United States may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation , provided all of the following conditions are met
• The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his / her professional practice
• The telemedicine communication is conducted using an : audio-visual ; real-time , two-way interactive communication system
• The practitioner is acting in accordance with applicable Federal and State laws .